SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-051928
Filing Date
2020-09-24
Accepted
2020-09-24 17:20:58
Documents
1
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3983
  Complete submission text file 0001209191-20-051928.txt   5396
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608
Business Address
Paradiso Peter R. (Reporting) CIK: 0001825347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 201196079